Indications and uses
For the temporary relief of nasal congestion due to the common cold, hay fever or other upper respiratory allergies.
For the temporary relief of nasal congestion due to the common cold, hay fever or other upper respiratory allergies.
Adults and children 6 to under 12 years of age (with adult supervision): 2 or 3 sprays in each nostril not more often than every 10 to 12 hours. Do not exceed 2 doses in any 24-hour period. Children under 6 years of age : consult a doctor.
Oxymetazoline Hydrochloride - 0.05% Nazal Decongestant
For the temporary relief of nasal congestion due to the common cold, hay fever or other upper respiratory allergies.
Do not use this product if person has heart disease, high blood pressure, thyroid disease, diabetes, or if adult has difficulty in urination due to enlargement of the prostate gland unless directed by a doctor.
When using this product
Do not exceed recommended dosage
Do not use this product for more than 3 days. Use only as directed. Frequent or prolonged use may cause nasal congestion to recur or worsen. If symptoms persist, consult a doctor.This product may cause temporary discomfort such as burning, stinging, sneezing, or an increase in nasal discharge. The use of this container by more than one person may spread infection.
Adults and children 6 to under 12 years of age (with adult supervision): 2 or 3 sprays in each nostril not more often than every 10 to 12 hours. Do not exceed 2 doses in any 24-hour period. Children under 6 years of age: consult a doctor.
Benzalkonium Chloride
Camphor
Disodium EDTA
Eucalyptol
Glycine
Menthol
Polysorbate 80
Propylene Glycol
Sodium Chloride
Sodium Hydroxide
Water
| Class | Version | Type | Effective |
|---|---|---|---|
| OXYMETAZOLINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| e67be450-f8e4-4bc1-88bd-1259d379f55f | Product name | 1 | 20210127 |
| c53f3286-4062-4cf5-8355-399519c639a6 | Product name | 1 | 20170424 |
| a993dfc5-f219-4460-bde6-30dd724d9ef0 | Product name | 1 | 20160818 |
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0363-7003-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-687d-f424-e053-dadaa90a57ce | Walgreens Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0363-7003-01 | Maximum Strenth Nasal | 22 mL in 1 BOTTLE | LIQUID | 22 | 3 | |
| 0363-7003-01 | Maximum Strenth Nasal | 1 in 1 CARTON | LIQUID | 1 | 3 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0363-7003-01 | ML - Milliliter | 0363-7003 | 746fce7b-f719-47c2-92b5-a5d0e3740fb3 | 1 | 2022-06-06 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 0363-7003 | 0363-7003-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Oxymetazoline Hydrochloride | K89MJ0S5VY | ACTIB |
| Benzalkonium Chloride | F5UM2KM3W7 | IACT |
| CAMPHOR (SYNTHETIC) | 5TJD82A1ET | IACT |
| EDETATE DISODIUM | 7FLD91C86K | IACT |
| Eucalyptol | RV6J6604TK | IACT |
| Glycine | TE7660XO1C | IACT |
| Menthol | L7T10EIP3A | IACT |
| Polysorbate 80 | 6OZP39ZG8H | IACT |
| Propylene Glycol | 6DC9Q167V3 | IACT |
| Sodium Chloride | 451W47IQ8X | IACT |
| Sodium Hydroxide | 55X04QC32I | IACT |
| water | 059QF0KO0R | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| bc7ea4dd-280c-4d01-833e-1dacca8541a2 | 5a5b301b-a224-41f5-8b62-c382c71e33e8 | 2018-02-19 | Warnings | bc7ea4dd-280c-4d01-833e-1dacca8541a2 5a5b301b-a224-41f5-8b62-c382c71e33e8 |
Adverse event summaries are temporarily unavailable. Other product information remains available.